Radial or Focus Extracorporeal Shock Wave Therapy in Epin Calcanei
Investigation of The Effectiveness of Extracorporeal Shock Wave Therapy in Patients Diagnosed With Epin Calcanei: Comparison of Radial and Focus Applications
1 other identifier
interventional
112
1 country
1
Brief Summary
Objective: The aim of the study was to investigate the effectiveness of radial and focused ESWT treatment on pain, function, and size of the calcaneal spur in patients with a clinical and radiological diagnosis of epin calcanei. Methods: A total of 112 patients aged between 18 and 95 years were randomly divided into two groups: group 1 received rESWT (2.4 bar 12 hz 2000 beats), and group 2 received fESWT (0.14 bar 14 hz 1000 beats) three times a week for three weeks. All patients were evaluated using the Visual Analog Scale (VAS)-pain and Foot Function Index (FFI) before and after the treatment, at 4 weeks and 12 weeks. Epin size was measured radiographically in the patients before and after the treatment at the 12-week follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2024
CompletedFirst Submitted
Initial submission to the registry
March 25, 2024
CompletedFirst Posted
Study publicly available on registry
April 10, 2024
CompletedApril 22, 2024
April 1, 2024
7 months
March 25, 2024
April 18, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Visual Analog Scale
0 min , 10 is maximum pain score
Before and after treatment baseline, 4th week, 12 th week
Functional Foot Index
0 is no pain 10 is max pain, and 0 is no deficiency 10 is the maximum deficiency and 0 is no activity limitation 10 is the maximum activity limitation score.
Before and after treatment baseline, 4th week, 12 th week
Secondary Outcomes (1)
Radiographic assesment, epin size
Before and after treatment baseline, 4th week, 12 th week
Study Arms (2)
rESWT( Radial Extracorporeal shock wave therapy)
EXPERIMENTALrESWT(2.4 bar, 12 hz, 2000 beats), to painful calcaneal area, three sessions, once a week, for total of three weeks
fESWT(Focused Extracorporeal shock wave therapy))
EXPERIMENTALfESWT (0.14 bar, 14 hz, 1000 beats), to painful calcaneal area, three sessions, once a week, for total of three weeks
Interventions
Radİal ESWT and focus ESWT
Eligibility Criteria
You may qualify if:
- Presence of heel pain for at least four weeks,
- Receiving no medical treatment, injection, physical or surgical treatment for the last four weeks and
- Agreed to participate in the study.
You may not qualify if:
- History of fracture or surgery,
- Polyneuropathy,
- Rheumatological diseases,
- Coagulation disorders,
- Tumor,
- Thrombosis,
- Soft tissue or bone infection,
- Pregnancy and lactation,
- Epilepsy,
- Presence of a pacemaker.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Özge TEZEN
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2024
First Posted
April 10, 2024
Study Start
May 15, 2023
Primary Completion
December 15, 2023
Study Completion
January 15, 2024
Last Updated
April 22, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
participant data will not share